Research Peptides In UK Stock
Retatrutide
£220.00
Retatrutide
£139.99
Weight Loss
£180.00
Weight Loss
£160.00
£120.00
£160.00
Recovery
£140.00
Anabolic
£120.00
Recovery
£169.00
Cosmetic
£50.00
Cosmetic
£89.99
What is a fair retatrutide price in the UK right now? The short answer: £120 to £180 for a 20mg research pen, £180 to £260 for a 40mg pen kit, and anything dramatically cheaper should worry you rather than excite you. This guide breaks down the retatrutide price landscape in 2026, from cost per milligram to monthly budgeting, so you can judge any listing in seconds.
Pricing context matters when judging any listing. Retatrutide remains an investigational compound with no marketing authorisation from the MHRA, so nothing on the UK market is priced as a licensed medicine. The trial data driving demand was published in the New England Journal of Medicine, and that evidence, not regulatory approval, is what moves this market.
These are the realistic market bands for research grade retatrutide pens sold from UK stock in 2026. Overseas listings often look cheaper until customs risk and lost parcels are priced in.
| Product | Typical UK retatrutide price | Cost per mg | Our price |
|---|---|---|---|
| Retatrutide 20mg pen | £120 to £180 | £6.00 to £9.00 | £139.99 |
| Retatrutide 40mg pen kit | £180 to £260 | £4.50 to £6.50 | £220.00 |
| Retatrutide 40mg pen price elsewhere (grey imports) | £90 to £150 | £2.25 to £3.75 | Not recommended |
| Branded pens (Alluvi, VLS, Viogen) | £150 to £280 | £3.75 to £7.00 | Not stocked |
The honest way to compare any retatrutide price is per milligram, not per pen. A £139.99 pen holding 20mg costs £7.00 per mg. A £220 kit holding 40mg costs £5.50 per mg, which is why larger pens usually win on value. When a listing does not state total milligrams clearly, you cannot calculate the real retatrutide price at all, and that is a reason to walk away. Genuine synthesis, purification and cold chain handling put a hard floor under production cost. Nobody sells real 40mg pens at £2 per mg and stays in business honestly.

Most researchers budget in monthly cycles, so the retatrutide price per month question comes up constantly. Published trial protocols used weekly amounts stepping up from 2mg to as high as 12mg. Mapped onto pen sizes, a lower range protocol consumes roughly 8 to 16mg per month, and a top range protocol up to 48mg. In practice that means one 20mg pen covers a month at the lower end, while heavier protocols consume a 40mg kit and part of a second.
Realistic monthly spend therefore runs from about £140 to £330 depending on the protocol studied. Licensed alternatives on private prescription run £150 to £250 every month for much smaller compounds doses, which is why the comparison keeps being made even though the products serve different legal purposes.
| Compound | Legal status in UK | Typical monthly cost |
|---|---|---|
| Retatrutide research pen | Research use only | £140 to £330 |
| Tirzepatide (licensed brand) | Prescription medicine | £150 to £250 |
| Semaglutide (licensed brand) | Prescription medicine | £120 to £250 |
| Retatrutide on the NHS | Not available, no licence | Not applicable |
The licensed column is there for context only. A research pen is not a substitute for a prescribed medicine, and no retatrutide price makes it one. If a licensed treatment is what you actually need, speak to a clinician about tirzepatide or semaglutide, which do hold MHRA licences.
Independent analyses of grey market peptides repeatedly find underdosed and contaminated product concentrated at the bottom of the price range. A pen sold at half the going retatrutide price has usually saved that money somewhere: less active compound, no testing, no cold chain or no product at all. The £60 bargain that contains 8mg instead of 40mg is the most expensive pen you can buy at any price. Judge every retatrutide price against the per milligram floor, check the seven supplier checks in our buy retatrutide UK guide, and be suspicious of outliers in both directions.
We keep pricing simple: two strengths, UK stock, tracked 48 hour delivery included, no hidden extras at checkout. Every pen is labelled for laboratory and research use only.
Pens are the standard UK format now, so it helps to see the retatrutide pen UK price picture strength by strength. At 10mg, listings are scarce and usually poor value, typically £80 to £110, which works out £8 to £11 per mg. At 20mg the market matures: £120 to £180 buys UK stock from reputable research suppliers, £6 to £9 per mg.
At 40mg the economics improve again, £180 to £260 for £4.50 to £6.50 per mg, and this is where most repeat buyers settle. Above 40mg, combined kits exist but gains per milligram flatten while single order risk concentrates, so we do not recommend chasing 60mg or 80mg bundles from unknown sellers just to shave the headline number.
Branded pens deserve a note of their own. Alluvi, VLS and Viogen pens circulate widely in UK groups, and their pricing sits £20 to £60 above equivalent unbranded research stock. You are paying for packaging and name recognition, not verified extra quality. Judge them by the same per milligram maths as everything else.
Early UK listings in 2024 priced 10mg vials at £90 or more, a per milligram cost near £9, because supply was thin and demand was driven by each new trial headline. Through 2025, pen format supply widened and the effective retatrutide price fell steadily, with 40mg kits settling under £260 for the first time. In 2026 pricing has been broadly stable, drifting a few pounds either way with currency movement.
If the MHRA grants a licence in 2027 as many expect, the research market will not disappear overnight, but history from semaglutide suggests research prices soften once a licensed route exists. Waiting for that moment, however, means waiting a year or more for a saving of perhaps 15 percent.
There are three honest ways to bring your effective cost down. First, buy the 40mg format rather than two 20mg pens, which saves roughly £60 per 40mg at our pricing. Second, order ahead of need rather than paying panic premiums when a batch sells through, because UK stock does sell out after big trial headlines. Third, follow our research blog where restocks and any price changes are announced first.
What we would never suggest: chasing the bottom of the market, splitting orders with strangers in group buys, or importing from unverified overseas sellers to save £40. Each of those trades a small saving for a large risk, and the whole point of understanding the retatrutide price landscape is to stop that trade being made blind.

UK research pens run £120 to £180 for 20mg and £180 to £260 for 40mg kits in 2026. Our prices are £139.99 and £220 respectively with tracked delivery included.
A fair retatrutide 40mg pen price from UK stock is £180 to £260. Ours is £220 including tracked 48 hour delivery. Grey imports advertised at £90 to £150 carry customs and authenticity risk.
Based on published trial protocols, monthly research consumption maps to roughly £140 at the lower end and up to £330 for top range protocols.
Peptide synthesis is genuinely costly. Multi step production, purification and refrigerated handling set a floor under the honest retatrutide price. Prices far below the market band usually mean corners were cut.
Per milligram, research retatrutide pens usually cost less than licensed tirzepatide pens on private prescription, but they are different legal products. One is a research chemical, the other is a regulated medicine.
A licensed retatrutide medicine would be priced by the manufacturer and negotiated for NHS use. Licensed launch prices for comparable injections started high. Research market prices tend to fall gradually as supply matures.